GlassScriptPhysician profile
Ameer Khowaja
NPI 1366672701
$27,992.35
in general payments reported to CMS, 2019-2025
60 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,935 · 2020: $2,564 · 2021: $2,863 · 2022: $3,841 · 2023: $2,641 · 2024: $2,344 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,945 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,472 · Travel and Lodging: $1,312 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,945.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,472.00 |
| Travel and Lodging | $1,312.16 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $9,582.00 | 2021-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $3,414.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Tandem Diabetes Care, INC. | $1,643.13 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $1,479.14 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $959.92 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $854.34 | 2020-2025 | Tepezza, Repatha, Evenity |
| Abbott Laboratories | $843.25 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $800.78 | 2019-2022 | |
| Mannkind Corporation | $722.40 | 2019-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $617.16 | 2019-2025 | Jardiance, Synjardy |
| Abbvie INC. | $566.16 | 2019-2025 | |
| Antares Pharma, INC. | $529.88 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Corcept Therapeutics | $469.83 | 2020-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $414.64 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $391.31 | 2020-2025 | Gvoke Hypopen, Recorlev, Keveyis |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $361.31 | 2021-2025 | Signifor Lar, Isturisa, Enjaymo |
| Radius Health, INC. | $355.66 | 2019-2025 | Tymlos |
| Amarin Pharma, INC. | $309.27 | 2019-2023 | |
| Medtronic, INC. | $294.67 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Medtronic Minimed, INC. | $267.25 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $255.04 | 2019-2022 | |
| Zealand Pharma US, INC. | $236.33 | 2021-2022 | |
| Eusa Pharma (US) LLC | $227.78 | 2022 | |
| Amneal Pharmaceuticals LLC | $177.97 | 2021-2025 | Unithroid |
| Beta Bionics, INC. | $168.16 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Merck Sharp & Dohme LLC | $154.52 | 2019 | |
| Cequr Corporation | $140.85 | 2022-2025 | Cequr Simplicity |
| Ibsa Pharma INC. | $131.25 | 2020-2024 | Tirosint, Tirosint, Licart |
| Horizon Therapeutics Plc | $127.89 | 2020-2023 | Tepezza |
| Paratek Pharmaceuticals, INC. | $124.99 | 2023 | Nuzyra |
| Ultragenyx Pharmaceutical INC. | $94.71 | 2020-2023 | |
| Neurocrine Biosciences, INC. | $94.33 | 2025 | |
| Sequel Med Tech, LLC | $93.90 | 2025 | Twiist |
| Kyowa Kirin, INC. | $86.31 | 2023-2025 | Crysvita |
| Averitas Pharma INC. | $85.20 | 2023-2024 | Qutenza |
| Bayer Healthcare Pharmaceuticals INC. | $80.58 | 2021-2023 | |
| Ascendis Pharma Endocrinology INC | $79.63 | 2025 | Yorvipath |
| Ipsen Biopharmaceuticals, INC | $73.88 | 2022-2023 | Somatuline Depot |
| Novartis Pharmaceuticals Corporation | $68.00 | 2022-2025 | |
| Esperion Therapeutics, INC. | $64.33 | 2020-2025 | Nexletol |
| Acerus Pharmaceuticals Corporation | $53.34 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $43.98 | 2021-2024 | Contrave |
| Pfizer INC. | $40.13 | 2022-2024 | |
| Chiesi USA, INC. | $37.86 | 2024-2025 | Mycapssa |
| Intuity Medical INC | $36.85 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Boston Scientific Corporation | $36.58 | 2024 | |
| Madrigal Pharmaceuticals | $34.87 | 2024-2025 | Rezdiffra, Resmetirom |
| Nalpropion Pharmaceuticals LLC | $31.69 | 2019 | |
| Grt US Holding, INC. | $26.77 | 2022 | |
| Nevro Corp. | $26.70 | 2023 | Senza |
| Althera Pharmaceuticals LLC | $25.20 | 2021 | |
| Ascensia Diabetes Care US INC. | $21.08 | 2024 | |
| Becton, Dickinson and Company | $20.88 | 2021 | |
| Enterra Medical, INC. | $20.21 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.15 | 2021 | |
| Amryt Pharma Holdings LTD | $18.82 | 2021 | |
| Lifescan, INC. | $16.56 | 2022 | |
| Valeritas, INC. | $13.29 | 2019 | |
| Shire North American Group INC | $12.77 | 2019 | |
| Opko Pharmaceuticals, LLC | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameer Khowaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.